http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2019131501-A
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_84885696ebe3b5a4de2970dcbd278571 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-48 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P1-16 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K36-064 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-14 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-16 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-20 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-08 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-107 |
| filingDate | 2018-01-30-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_9621f4163ff0659c98e3379e9bbf5e58 |
| publicationDate | 2019-08-08-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | JP-2019131501-A |
| titleOfInvention | Liver disease therapeutic agent and use thereof |
| abstract | A novel therapeutic agent for liver disease and a pharmaceutical composition for treating liver disease are provided. The therapeutic agent for liver disease of the present invention contains yeast cells or culture as an active ingredient. In the therapeutic agent for liver disease, the yeast is preferably a yeast belonging to the genus Saccharomyces. The pharmaceutical composition for treating liver disease of the present invention comprises the therapeutic agent for liver disease and a pharmaceutically acceptable carrier or diluent. In the pharmaceutical composition for treating liver disease, the yeast is preferably a yeast belonging to the genus Saccharomyces. [Selection figure] None |
| priorityDate | 2018-01-30-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 68.